BioCentury | Jul 14, 2016
Product R&D
Agonistic families
...nucleic acid-based therapy targeting a TNF family member is in clinical development. eTheRNA N.V. and Progress Pharma N.V....
...NASDAQ:CELG), Summit, N.J. Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Palo Alto, Calif. eTheRNA N.V., Brussels, Belgium Progress Pharma N.V....
...NASDAQ:CELG), Summit, N.J. Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Palo Alto, Calif. eTheRNA N.V., Brussels, Belgium Progress Pharma N.V....
